UY24370A1 - Nuevos taxoides,eterificados en posición 7 y 10, su preparación y composiciones farmacéuticas parenterales que los contienen - Google Patents

Nuevos taxoides,eterificados en posición 7 y 10, su preparación y composiciones farmacéuticas parenterales que los contienen

Info

Publication number
UY24370A1
UY24370A1 UY24370A UY24370A UY24370A1 UY 24370 A1 UY24370 A1 UY 24370A1 UY 24370 A UY24370 A UY 24370A UY 24370 A UY24370 A UY 24370A UY 24370 A1 UY24370 A1 UY 24370A1
Authority
UY
Uruguay
Prior art keywords
eterified
contain
preparation
pharmaceutical compositions
parenteral pharmaceutical
Prior art date
Application number
UY24370A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9503545A external-priority patent/FR2732340B1/fr
Priority claimed from FR9515381A external-priority patent/FR2742754B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of UY24370A1 publication Critical patent/UY24370A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
UY24370A 1995-03-27 1996-11-20 Nuevos taxoides,eterificados en posición 7 y 10, su preparación y composiciones farmacéuticas parenterales que los contienen UY24370A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9503545A FR2732340B1 (fr) 1995-03-27 1995-03-27 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR9515381A FR2742754B1 (fr) 1995-12-22 1995-12-22 Procede de preparation de taxoides

Publications (1)

Publication Number Publication Date
UY24370A1 true UY24370A1 (es) 2001-10-25

Family

ID=26231838

Family Applications (2)

Application Number Title Priority Date Filing Date
UY24192A UY24192A1 (es) 1995-03-27 1996-03-27 Nuevos taxoides, su preparacion y las composiciones farmaceuticas que los contienen
UY24370A UY24370A1 (es) 1995-03-27 1996-11-20 Nuevos taxoides,eterificados en posición 7 y 10, su preparación y composiciones farmacéuticas parenterales que los contienen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY24192A UY24192A1 (es) 1995-03-27 1996-03-27 Nuevos taxoides, su preparacion y las composiciones farmaceuticas que los contienen

Country Status (41)

Country Link
US (3) US5889043A (es)
EP (2) EP0817780B1 (es)
JP (2) JP3790826B2 (es)
KR (2) KR100297196B1 (es)
CN (2) CN1213042C (es)
AP (2) AP785A (es)
AR (1) AR001440A1 (es)
AT (2) ATE185562T1 (es)
AU (2) AU711227B2 (es)
BG (2) BG63121B1 (es)
BR (2) BR9607929A (es)
CA (2) CA2214321C (es)
CO (1) CO4700576A1 (es)
CZ (2) CZ287468B6 (es)
DE (2) DE69606028T2 (es)
DK (2) DK0817780T3 (es)
DZ (1) DZ2009A1 (es)
EA (2) EA000567B1 (es)
EE (2) EE03608B1 (es)
ES (2) ES2143187T3 (es)
GE (2) GEP20002211B (es)
GR (2) GR3031526T3 (es)
HU (2) HU223666B1 (es)
IL (1) IL117636A (es)
IS (2) IS2058B (es)
MA (1) MA23823A1 (es)
MY (1) MY121225A (es)
NO (2) NO316379B1 (es)
NZ (2) NZ304900A (es)
OA (2) OA10513A (es)
PE (1) PE51097A1 (es)
PL (2) PL188284B1 (es)
PT (1) PT817779E (es)
RO (2) RO115878B1 (es)
SK (2) SK281927B6 (es)
TN (1) TNSN96043A1 (es)
TR (2) TR199701040T1 (es)
TW (1) TW394765B (es)
UY (2) UY24192A1 (es)
WO (2) WO1996030356A1 (es)
ZA (1) ZA962399B (es)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US5811452A (en) * 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US7288665B1 (en) * 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
FR2771092B1 (fr) * 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
JP2002523364A (ja) * 1998-08-20 2002-07-30 アベンテイス・フアルマ・ソシエテ・アノニム タキソイド誘導体の新規な使用
EP0982028A1 (en) * 1998-08-20 2000-03-01 Aventis Pharma S.A. New use of taxoid derivatives
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
NZ514406A (en) 2000-02-02 2005-01-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents
CZ2003837A3 (cs) 2000-09-22 2004-12-15 Bristol-Myers Squibb Company Způsob pro snížení toxicity při kombinovaných chemoterapiích
WO2002024178A2 (en) * 2000-09-22 2002-03-28 Bristol-Myers Squibb Company Method for reducing toxicity of combined chemotherapies
US6593334B1 (en) 2002-05-02 2003-07-15 The University Of North Carolina At Chapel Hill Camptothecin-taxoid conjugates as antimitotic and antitumor agents
KR20120104412A (ko) 2002-09-06 2012-09-20 인설트 테라페틱스, 인코퍼레이티드 공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
AU2003291458A1 (en) * 2002-11-08 2004-06-03 Bristol-Myers Squibb Company Pharmaceutical compositions and methods of using taxane derivatives
US20080107721A1 (en) * 2003-05-20 2008-05-08 Jonathan Lewis Combination Chemotherapy Comprising A Liposomal Platinum Complex
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
HN2005000054A (es) * 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
GT200500025A (es) * 2004-02-13 2005-09-30 Taxanos sustituidos con esteres de ciclopentilo en c10
AU2006214498A1 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
PL1871753T3 (pl) * 2005-03-31 2012-12-31 Accord Healthcare Inc Wytwarzanie taksanów z 9-dihydro-13-acetylobakatyny iii
DK1948669T3 (da) * 2005-11-04 2013-10-07 Accord Healthcare Inc Nye fremgangsmåder til fremstiling af taxaner under anvendelse af chirale hjælpestoffer
US7847111B2 (en) * 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
WO2008067403A2 (en) * 2006-11-28 2008-06-05 Encore Health Llc Presbyopia treatment by lens alteration
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
WO2009006590A2 (en) * 2007-07-04 2009-01-08 Dr. Reddy's Laboratories Ltd. Docetaxel process and polymorphs
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
WO2009145981A1 (en) 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes
MX2011001583A (es) 2008-08-11 2011-04-04 Nektar Therapeutics Conjugados de alcanoato polimericos de multiples brazos.
FR2945211A1 (fr) 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
BR112012011457A2 (pt) 2009-10-29 2016-05-03 Aventis Pharma Sa uso antitumoral de cabazitaxel.
EA201200617A1 (ru) * 2009-11-23 2012-11-30 Серулин Фарма Инк. Полимеры на основе циклодекстрина для доставки лекарственных средств
US8791279B2 (en) * 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
WO2012088433A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
CN102060815B (zh) * 2010-12-24 2012-09-26 重庆泰濠制药有限公司 一种紫杉烷类化合物的制备方法
EP2620148A1 (en) 2012-01-27 2013-07-31 Aventis Pharma S.A. Antitumoral combination comprising cabazitaxel and cisplatin
EP2491925A1 (en) 2011-02-25 2012-08-29 Aventis Pharma S.A. Antitumoral combination comprising cabazitaxel and cisplatin
HUE046232T2 (hu) 2011-02-25 2020-02-28 Sanofi Mature Ip Kabazitaxelt és ciszplatint tartalmazó tumorellenes kombináció
KR20140018917A (ko) 2011-04-12 2014-02-13 플러스 케미칼스, 에스.에이. 카바지탁셀의 고상 형태 및 이의 제조 방법
TW201316990A (zh) 2011-08-02 2013-05-01 Astellas Pharma Inc 藥劑併用之癌治療方法
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
EP2760848B1 (en) * 2011-09-26 2018-11-28 Fresenius Kabi Oncology Limited Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
CN102336726B (zh) * 2011-09-30 2014-11-26 重庆泰濠制药有限公司 一种卡巴他赛的制备方法
US20130090484A1 (en) * 2011-10-11 2013-04-11 Scinopharm Taiwan Ltd. Process for making an intermediate of cabazitaxel
CN102408397B (zh) * 2011-10-19 2014-08-20 上海贝美医药科技有限公司 紫杉烷类衍生物及其制备方法
CN102516281B (zh) * 2011-10-20 2015-02-04 江苏红豆杉生物科技股份有限公司 一种10-脱乙酰基巴卡丁iii及其衍生物甲氧基化的方法
CN102603724B (zh) * 2011-10-20 2014-02-26 江苏红豆杉生物科技股份有限公司 二甲氧基紫杉烷类化合物纯化精制的方法
CN102424672A (zh) * 2011-10-20 2012-04-25 江苏红豆杉生物科技有限公司 脱保护基制备二甲氧基紫杉烷类化合物的方法
WO2013072766A2 (en) * 2011-10-31 2013-05-23 Scinopharm Taiwan, Ltd. Process for cabazitaxel and intermediates thereof
CN102417491B (zh) * 2011-10-31 2013-11-06 江苏红豆杉生物科技有限公司 以10-去乙酰基-巴卡丁iii为原料制备卡巴他赛的方法
WO2013065070A1 (en) * 2011-11-01 2013-05-10 Fresenius Kabi Encology Ltd. Amorphous form of cabazitaxel and process for its preparation
CN103159705B (zh) * 2011-12-12 2015-05-27 福建南方制药股份有限公司 卡巴他赛中间体的制备方法
JP6025861B2 (ja) 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの結晶形およびこれを調製するための方法
CN102532064B (zh) * 2011-12-13 2015-06-17 重庆泰濠制药有限公司 二甲氧基多西他赛的合成方法
EP2880021A4 (en) * 2012-07-31 2015-06-17 Yung Shin Pharm Ind Co Ltd AMORPHIC CABACITAXEL
CN102775435B (zh) * 2012-08-21 2015-04-08 江苏红豆杉生物科技股份有限公司 一种用于制备7,10-甲氧基多西他赛的中间体的合成方法
CN102775434B (zh) * 2012-08-21 2015-04-08 江苏红豆杉生物科技股份有限公司 一种7,10-二甲氧基紫杉烷化合物中间体的合成方法
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
KR101407353B1 (ko) * 2012-12-04 2014-06-17 주식회사 삼양바이오팜 10-디아세틸바카틴 iii으로부터 카바지탁셀을 고수율로 제조하는 새로운 방법 및 이를 위한 신규 중간체
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物
CN104086514A (zh) * 2014-06-19 2014-10-08 上海应用技术学院 紫杉醇衍生物及其制备方法
EP3258931B1 (en) 2015-02-17 2020-08-12 Erasmus University Medical Center Rotterdam Use of cabazitaxel in the treatment of prostate cancer
EP3093014A1 (en) 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
EP4009969A1 (en) 2019-08-08 2022-06-15 Laekna Limited Method of treating cancer
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5229526A (en) 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5489601A (en) 1991-09-23 1996-02-06 Florida State University Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US5739362A (en) 1991-09-23 1998-04-14 Florida State University Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US5319112A (en) 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
FR2696459B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
NO310238B1 (no) 1992-12-24 2001-06-11 Bristol Myers Squibb Co Kjemiske forbindelser og farmasöytisk preparat samt anvendelse av slike preparater
ZA94128B (en) * 1993-02-01 1994-08-19 Univ New York State Res Found Process for the preparation of taxane derivatives and betalactam intermediates therefor
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
AU695873B2 (en) 1993-12-21 1998-08-27 University Of Hawaii New cryptophycins
ES2123996T3 (es) 1994-06-28 1999-01-16 Upjohn Co Analogos de 7-etertaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.
US6201140B1 (en) 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives
US5481018A (en) 1995-03-31 1996-01-02 The Dow Chemical Company Amino nitrile intermediate for the preparation of alanine diacetic acid
FR2745814B1 (fr) 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides

Also Published As

Publication number Publication date
US6387946B1 (en) 2002-05-14
HUP9801201A3 (en) 2000-12-28
HUP9801204A1 (hu) 2000-05-28
DK0817779T3 (da) 2000-06-19
KR19980703287A (ko) 1998-10-15
TW394765B (en) 2000-06-21
DE69606028T2 (de) 2000-08-10
SK130197A3 (en) 1998-04-08
AP753A (en) 1999-07-21
BG63009B1 (bg) 2001-01-31
NO973922D0 (no) 1997-08-26
CA2214319A1 (fr) 1996-10-03
MY121225A (en) 2006-01-28
PT817779E (pt) 2000-04-28
EA000567B1 (ru) 1999-12-29
BG101918A (en) 1998-10-30
CZ287468B6 (en) 2000-12-13
HU223666B1 (hu) 2004-11-29
DE69606028D1 (de) 2000-02-10
IL117636A (en) 2004-08-31
AU5278196A (en) 1996-10-16
AP9701090A0 (en) 1997-10-31
CZ303297A3 (cs) 1998-01-14
JP2941951B2 (ja) 1999-08-30
AR001440A1 (es) 1997-10-22
EP0817780A1 (fr) 1998-01-14
JP3790826B2 (ja) 2006-06-28
JPH11500141A (ja) 1999-01-06
CN1179776A (zh) 1998-04-22
EA199700269A1 (ru) 1998-04-30
ES2143187T3 (es) 2000-05-01
OA10514A (fr) 2002-04-22
AU5278096A (en) 1996-10-16
SK281927B6 (sk) 2001-09-11
SK281928B6 (sk) 2001-09-11
NO316607B1 (no) 2004-03-08
HUP9801204A3 (en) 2000-12-28
BG63121B1 (bg) 2001-04-30
EP0817779A1 (fr) 1998-01-14
HUP9801201A2 (hu) 2000-05-28
JPH11502531A (ja) 1999-03-02
KR100485309B1 (ko) 2005-10-12
HU223732B1 (hu) 2004-12-28
WO1996030355A1 (fr) 1996-10-03
CZ303097A3 (cs) 1998-01-14
RO115877B1 (ro) 2000-07-28
GEP20002211B (en) 2000-08-25
AU703278B2 (en) 1999-03-25
IS4567A (is) 1997-09-23
RO115878B1 (ro) 2000-07-28
CN1179775A (zh) 1998-04-22
BR9607929A (pt) 1998-06-02
TR199701042T1 (xx) 1998-01-21
IS2056B (is) 2005-10-14
EE9700315A (et) 1998-06-15
EP0817780B1 (fr) 1999-10-13
GR3031526T3 (en) 2000-01-31
NZ304900A (en) 1998-09-24
DZ2009A1 (fr) 2002-10-23
NZ304901A (en) 1998-12-23
EA199700270A1 (ru) 1998-02-26
EA000709B1 (ru) 2000-02-28
ATE188471T1 (de) 2000-01-15
US20020038038A1 (en) 2002-03-28
NO973923L (no) 1997-08-26
DE69604653D1 (de) 1999-11-18
OA10513A (fr) 2002-04-22
ATE185562T1 (de) 1999-10-15
MX9706568A (es) 1997-11-29
CO4700576A1 (es) 1998-12-29
NO973923D0 (no) 1997-08-26
KR19980703357A (ko) 1998-10-15
NO316379B1 (no) 2004-01-19
PL322465A1 (en) 1998-02-02
MX9706278A (es) 1997-10-31
PL188987B1 (pl) 2005-05-31
IS2058B (is) 2005-10-14
CZ287326B6 (en) 2000-10-11
BG101917A (en) 1998-10-30
IS4536A (is) 1997-07-31
CN1152870C (zh) 2004-06-09
EE03609B1 (et) 2002-02-15
GR3032316T3 (en) 2000-04-27
UY24192A1 (es) 1996-06-14
CA2214321A1 (fr) 1996-10-03
BR9607930A (pt) 1998-06-02
AP785A (en) 1999-11-26
TNSN96043A1 (fr) 2005-03-15
GEP20002188B (en) 2000-07-25
ZA962399B (en) 1996-10-01
AP9701093A0 (en) 1997-10-31
CN1213042C (zh) 2005-08-03
MA23823A1 (fr) 1996-10-01
KR100297196B1 (ko) 2001-11-22
ES2140075T3 (es) 2000-02-16
CA2214319C (fr) 2004-02-17
IL117636A0 (en) 1996-07-23
SK130297A3 (en) 1998-03-04
DE69604653T2 (de) 2000-05-31
EE9700323A (et) 1998-06-15
PE51097A1 (es) 1997-12-22
WO1996030356A1 (fr) 1996-10-03
PL188284B1 (pl) 2005-01-31
NO973922L (no) 1997-08-26
CA2214321C (fr) 2008-01-22
PL322499A1 (en) 1998-02-02
EP0817779B1 (fr) 2000-01-05
US5889043A (en) 1999-03-30
DK0817780T3 (da) 2000-03-27
TR199701040T1 (xx) 1998-01-21
EE03608B1 (et) 2002-02-15
AU711227B2 (en) 1999-10-07
US6331635B1 (en) 2001-12-18

Similar Documents

Publication Publication Date Title
UY24370A1 (es) Nuevos taxoides,eterificados en posición 7 y 10, su preparación y composiciones farmacéuticas parenterales que los contienen
DE69618587T2 (de) Chinazoline und pharmazeutische zusammensetzungen
IS4706A (is) Lyfjasamsetningar
DE69634514D1 (de) Gefärbte gegenstände und zusammensetzungen
NO962606D0 (no) Farmasöytisk sammensetning
ZA9610737B (en) Taxoids their preparation and pharmaceutical compositions containing them
FI943569A (fi) Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia
DE69621722T2 (de) Organopolysiloxan-derivate
DE69403708T2 (de) Organopolysiloxan-Zusammensetzungen
MX9100613A (es) Corticoide-17-alquilcarbonatos sustituidos en posicion 17,procedimientos para su preparacion,y medicamentos que los contienen
ZA962900B (en) Taxoids their preparation and pharmaceutical compositions which contain them
BR9509688A (pt) Composto e composição farmacêutica
DE69614407T2 (de) Pharmazeutische zusammensetzungen
IL117760A0 (en) Taxoids, their preparation and pharmaceutical compositions containing them
FI973229A (fi) Uusi farmaseuttinen koostumus
ITMI912261A0 (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
FI971462A0 (fi) Bentsisoksatsolijohdannaisia ja niitä sisältäviä torjuntaainekoostumuksia
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
ZA954655B (en) Novel taxoids their preparation and the pharmaceutical compositions which contain them
FI955335A0 (fi) Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav foer anvaendning som kontrastmedel och foerfarande foer framstaellning av dessa
ZA962400B (en) Taxoids their preparation and pharmaceutical compositions containing them
ZA9610740B (en) Taxoids their preparation and pharmaceutical compositions containing them
DE69114237D1 (de) Molekular mischbare Polymerzusammensetzungen.
FI962738A0 (fi) Farmaseuttiset koostumukset
ITMI911888A0 (it) Composizioni farmaceutiche utilizzabili in gastroenterologia

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20161120